Akbas H, Ozden M, Kanko M, Maral H, Bulbul S, Yavuz S, Ozker E, Berki T
Department of Cardiovascular Surgery, Kocaeli University School of Medicine, Kocaeli, Turkey.
J Int Med Res. 2005 Sep-Oct;33(5):528-36. doi: 10.1177/147323000503300508.
This study investigated the protective effects of carvedilol, a potent antioxidant, in a rat model of tourniquet-induced ischaemia-reperfusion injury of the hind limb. Thirty rats were divided equally into three groups: the control group (group 1) was only anaesthetized, without creating an ischaemia-reperfusion injury; group 2 was submitted to ischaemia (4 h), followed by a 2-h reperfusion period; and group 3 was pre-treated with carvedilol (2 mg/kg per day) for 10 days prior to ischaemia-reperfusion. Ischaemia-reperfusion produced a significant decrease in superoxide dismutase and glutathione peroxidase activities in the liver, lungs, muscle and serum compared with control treatment, and pre-treatment with carvedilol prevented these changes. Ischaemia-reperfusion caused a significant increase in malondialdehyde and nitric oxide (NO) levels in liver, lungs, muscle (except NO) and serum compared with control treatment, and carvedilol prevented these changes. In conclusion, it might be inferred that carvedilol could be used safely to prevent oxidative injury during reperfusion following ischaemia in humans.
本研究在大鼠后肢止血带所致缺血-再灌注损伤模型中,研究了强效抗氧化剂卡维地洛的保护作用。30只大鼠平均分为三组:对照组(第1组)仅接受麻醉,未造成缺血-再灌注损伤;第2组经历缺血(4小时),随后再灌注2小时;第3组在缺血-再灌注前10天用卡维地洛(每天2毫克/千克)预处理。与对照处理相比,缺血-再灌注导致肝脏、肺、肌肉和血清中的超氧化物歧化酶和谷胱甘肽过氧化物酶活性显著降低,而卡维地洛预处理可防止这些变化。与对照处理相比,缺血-再灌注导致肝脏、肺、肌肉(一氧化氮除外)和血清中的丙二醛和一氧化氮(NO)水平显著升高,卡维地洛可防止这些变化。总之,可以推断卡维地洛可安全用于预防人类缺血后再灌注期间的氧化损伤。